We’ve waited 18 years for this. No, we’re not talking about a sequel to Napoleon Dynamite. We’ll still have to wonder if Kip’s cage fighting-career ever takes off. Instead, we’re talking about the update to the Centers for Disease Control and Prevention’s (CDC) 2004 developmental surveillance checklist . . .

Read more »

A new pilot study suggests that a nonpharmacologic, cost-free, simple, and quick intervention may help prevent vasovagal syncope (VVS). Excellent! You had us at nonpharmacologic—those treatments are as welcome as pizza and wings on Super Bowl Sunday.

Read more »

The ever-insightful George Costanza must have been talking about e-cigarettes when he opined, “This thing is like an onion. The more layers you peel, the more it stinks.”

Read more »

Opioid misuse and overdose is an ongoing epidemic and public health emergency in the United States. Almost 850,000 people have died from a drug overdose since 1999.1 Over 70,000 people died in 2019, and 70% of them involved an opioid.1 This article will detail the rise of the opioid epidemic, highlight how educational and governmental institutions have responded to the crisis through education campaigns directed toward clinicians, and describe the Centers for Disease Control’s (CDC) guidelines for prescribing opioids for chronic pain in the United States.

Read more »

Drug overdose is the leading cause of injury-related death in the United States. In 2019, over 70,000 people died from a drug overdose, and over 70% involved a prescription or illicit opioid. Prescription opioid use has been a significant contributor to the opioid epidemic since the early 2000s.

Read more »

It’s that time of year again. As reliably as Tom Brady secures a spot in the playoffs every winter, the American Diabetes Association (ADA) releases its annual updates to the Standards of Medical Care in Diabetes. This year’s recommendations offer several key changes.

Read more »

Migraine is a widespread neurologic problem. It affects 1 billion people worldwide and almost 40 million people in the United States.1 The primary care clinician needs to understand the management options for preventing and acutely treating migraine. In this article, learn about the epidemiology of migraine, the pathophysiologic mechanisms behind migraine pain, options for the prevention and acute treatment of migraine, and the newest FDA-approved agents.

Read more »

As you may already know, the use of preexposure prophylaxis (PrEP) has been proven safe and effective in reducing the risk of sexual HIV acquisition. The problem is that it’s not getting prescribed to everyone who needs and wants it.

Read more »

In a study that will inevitably be made into a Hallmark movie, researchers have uncovered a remarkable phenomenon: when long-time couples are in close proximity to each other, their heart rates sync up like a crowd of strangers catching the first beats of “We Will Rock You.”

Read more »

People with chronic coronary artery disease live with an ongoing inflammatory battle inside their major blood vessels. This creates arterial plaque which can eventually rupture, leading to thrombosis. Scientists have been searching for a way to combat this inflammatory process, and colchicine is an old drug with potential new use in this patient population.

Read more »